Technical Analysis for VXRT - Vaxart, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Support | Bullish | 7.41% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 7.41% | |
Spinning Top | Other | 7.41% | |
Outside Day | Range Expansion | 7.41% | |
Down 3 Days in a Row | Weakness | 7.41% | |
Down 4 Days in a Row | Weakness | 7.41% | |
Down 5 Days in a Row | Weakness | 7.41% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 16 hours ago |
Rose Above 10 DMA | about 16 hours ago |
Possible Inside Day | about 16 hours ago |
Gap Up Closed | about 20 hours ago |
Gap Up Partially Closed | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Coronavirus Influenza Vaccines Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Coronavirus Influenza Vaccines Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.59 |
52 Week Low | 0.53 |
Average Volume | 2,135,051 |
200-Day Moving Average | 0.82 |
50-Day Moving Average | 1.04 |
20-Day Moving Average | 1.21 |
10-Day Moving Average | 1.15 |
Average True Range | 0.09 |
RSI (14) | 51.22 |
ADX | 26.29 |
+DI | 18.11 |
-DI | 23.18 |
Chandelier Exit (Long, 3 ATRs) | 1.26 |
Chandelier Exit (Short, 3 ATRs) | 1.31 |
Upper Bollinger Bands | 1.39 |
Lower Bollinger Band | 1.04 |
Percent B (%b) | 0.35 |
BandWidth | 28.55 |
MACD Line | 0.01 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.0255 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.28 | ||||
Resistance 3 (R3) | 1.27 | 1.21 | 1.26 | ||
Resistance 2 (R2) | 1.21 | 1.18 | 1.22 | 1.25 | |
Resistance 1 (R1) | 1.19 | 1.16 | 1.20 | 1.20 | 1.25 |
Pivot Point | 1.13 | 1.13 | 1.14 | 1.14 | 1.13 |
Support 1 (S1) | 1.11 | 1.10 | 1.12 | 1.12 | 1.07 |
Support 2 (S2) | 1.05 | 1.08 | 1.06 | 1.07 | |
Support 3 (S3) | 1.03 | 1.05 | 1.06 | ||
Support 4 (S4) | 1.04 |